FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Posted:

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.

Read more here.

Previous post
Back to list
Next post